Page last updated: 2024-08-24

gemcitabine and rs 504393

gemcitabine has been researched along with rs 504393 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Fan, J; Jiang, JT; Liu, ZH; Mu, XY; Sun, F; Tan, MY; Wang, RJ; Wang, X; Wu, K; Yao, ZX; Zheng, JH; Zheng, Z	1

Other Studies

1 other study(ies) available for gemcitabine and rs 504393

Article	Year
RS 504393 inhibits M-MDSCs recruiting in immune microenvironment of bladder cancer after gemcitabine treatment. Molecular immunology, 2019, Volume: 109 Topics: Animals; Benzoxazines; Cell Line, Tumor; Chemokine CCL2; Deoxycytidine; Female; Gemcitabine; Humans; Male; Mice; Middle Aged; Monocytes; Myeloid-Derived Suppressor Cells; Spiro Compounds; Survival Analysis; T-Lymphocytes; Tumor Microenvironment; Urinary Bladder Neoplasms	2019

Article

Year

RS 504393 inhibits M-MDSCs recruiting in immune microenvironment of bladder cancer after gemcitabine treatment.

Molecular immunology, 2019, Volume: 109

Topics: Animals; Benzoxazines; Cell Line, Tumor; Chemokine CCL2; Deoxycytidine; Female; Gemcitabine; Humans; Male; Mice; Middle Aged; Monocytes; Myeloid-Derived Suppressor Cells; Spiro Compounds; Survival Analysis; T-Lymphocytes; Tumor Microenvironment; Urinary Bladder Neoplasms

2019